Method of administering a Thymosin alpha 1 peptide

Details for Australian Patent Application No. 2002363248 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Tuthill, Cynthia W; Rudolph, Alfred R

Agent Wrays

Pub. Number AU-B-2002363248

PCT Number PCT/US02/35093

PCT Pub. Number WO2003/037366

Priority 60/330,874 01.11.01 US

Filing date 1 November 2002

Wipo publication date 12 May 2003

Acceptance publication date 22 November 2007

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 June 2003 Complete Application Filed

  Priority application(s): 60/330,874 01.11.01 US

10 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363248

22 November 2007 Application Accepted

  Published as AU-B-2002363248

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363249-METHODS FOR INHIBITING LENTIVIRUS REPLICATION

2002363247-GAME WITH PIVOTING POINTER